HTR2A and schizophrenia: A recent study showed for the first time that ketanserin significantly reduced chronic, intractable visual hallucniation but not auditory hallucination in schizophrenia, suggesting a possible role of the 5‐HT2A in the pathophysiology of visual hallucinations (Sommer et al., 2018).